DES

DES, diethylstilbestrol - marketed under a number of names including Stilbestrol, Stilbetin, and Dienestrol - was widely prescribed, from 1938 to 1971, to expectant mothers under the assumption that DES promoted healthy pregnancies by lowering the chances of miscarriage and premature labor.

In 1971, it was discovered that females exposed to DES, while still in the womb, ran an increased risk for developing a rare form of vaginal and cervical cancer, known as Clear Cell Adenocarcinoma, in their teens and twenties. Several years later it was discovered that menopausal and post-menopausal women had an increase risk of developing DES related cancers. In 1971, the FDA banned DES. And fortunately, the risk of developing cancer, stemming from the use of DES, is limited to one in a thousand.

Risks Associated with DES to Exposed Women

The greater and more pervasive risks than contracting a DES related cancer are Reproductive Tract Abnormalities and High-Risk Pregnancies.

Uterine, cervical, and fallopian tube abnormalities - cervical hood, T-shape uterus, clubbed & obstructed tubes - lead and contribute to:

  • Infertility;
  • Inability to Carry-to-Term;
  • Miscarriage;
  • Stillbirth;
  • Premature Delivery;
  • Ectopic Pregnancy;
  • Hysterectomy.

If you were exposed to DES in utero, because your mother took DES while pregnant, and suffer from any of these symptoms and conditions, you may be entitled to compensation. Levy Phillips & Konigsberg, LLP has obtained substantial recoveries for women who were rendered infertile because of their exposure to DES.

Taking legal action against a drug manufacturer for injuries caused by pharmaceuticals, the usual standards of product liability apply: strict liability, negligence, and breach of warranty. If a physician's conduct is to blame, a medical malpractice suit may be justified.

To successfully prosecute a DES case, you need a law firm with skill, knowledge, and the resources to win.

For more information, please call 212.605.6200 or submit a confidential email inquiry (see form above).

Share
 

DO YOU HAVE A CASE? FIND OUT NOW!

Your Name (*) Please let us know your name
Your Phone Number Invalid Input
Your Email Address (*) Please let us know your email address
Type of Case Invalid Input
About the Case (*) Please provide us with case details
Verify the anti-spam code: Verify the anti-spam code:
Invalid code. Please, try again.

NEW YORK OFFICES

new york city800 Third Avenue, 11th Floor
New York, New York 10022
Telephone: 212.605.6200
goshen new york42 Park Place
Goshen, New York 10924
Telephone: 845.294.2002

NEW JERSEY OFFICE

new jersey101 Grovers Mill Rd, Ste 105
Lawrence, New Jersey 08648
Telephone: 609.720.0400

CALIFORNIA OFFICE

los angeles10990 Wilshire Blvd, Ste 1025
Los Angeles, California 90024
Telephone: 800.988.8005

CONNECT WITH US ON FACEBOOK

VOTE FOR OUR WEBSITE ON GOOGLE

  If you like our website, let Google know about it by pressing the +1 button. Thank you!
We have 40 guests online